KYM (KLSE:KYM) unit KYM Healthcare signed a conditional deal to acquire a 70% stake in Regen Healthcare for up to 33.5 million ringgit in cash.
Following completion, Regen will become a 70%-owned subsidiary of KYM, while the vendor, Associate Prof. Dr. Rajesh Singh will retain the remaining 30% stake.
KYM also plans to diversify its principal activities to include healthcare activities and specialised medical services.
The deal is expected to be completed in the first quarter of 2027.
The company will finance the consideration through a combination of internally generated funds and/or bank borrowings, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments